| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.26 | 0.0009 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |